Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carroll

Showing results (1361-1370 of 1,449) with videos related to

Pageof 145
Sort By:
Gut Microbes|November 5, 2024
Giardia antagonizes beneficial functions of indigenous and therapeutic intestinal bacteria during protein deficiencyAadra P Bhatt, Jason W Arnold, Muyiwa Awoniyi, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudyAndrzej S Januszewski, Michael L H Huang, Abubakar Mangani, et al.
British Journal of Pharmacology|January 13, 2022
Linking drug and food addiction via compulsive appetiteAmanda Laque, Grant E Wagner, Alessandra Matzeu, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Identification of a broad-spectrum azasordarin with improved pharmacokinetic propertiesMichael H Serrano-Wu, Denis R St Laurent, Tina M Carroll, et al.
Contemporary Clinical Trials|November 17, 2011
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials NetworkAimee N C Campbell, Edward V Nunes, Gloria M Miele, et al.
Addiction (Abingdon, England)|July 26, 2011
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trialsDennis M Donovan, George E Bigelow, Gregory S Brigham, et al.
AIDS and Behavior|December 8, 2009
Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western KenyaRebecca K Papas, John E Sidle, Steve Martino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2003
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytesAjay Madan, Richard A Graham, Kathleen M Carroll, et al.
Cancer Research|March 26, 2009
Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cellsSudhir S Rao, Jennifer O'Neil, Cole D Liberator, et al.
Scientific Reports|June 4, 2021
Insulin micro-secretion in Type 1 diabetes and related microRNA profilesAndrzej S Januszewski, Yoon Hi Cho, Mugdha V Joglekar, et al.
Pageof 145

Showing results (1361-1370 of 1,449) with videos related to

Sort By:
Pageof 145
Gut Microbes|November 5, 2024
Giardia antagonizes beneficial functions of indigenous and therapeutic intestinal bacteria during protein deficiencyAadra P Bhatt, Jason W Arnold, Muyiwa Awoniyi, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudyAndrzej S Januszewski, Michael L H Huang, Abubakar Mangani, et al.
British Journal of Pharmacology|January 13, 2022
Linking drug and food addiction via compulsive appetiteAmanda Laque, Grant E Wagner, Alessandra Matzeu, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Identification of a broad-spectrum azasordarin with improved pharmacokinetic propertiesMichael H Serrano-Wu, Denis R St Laurent, Tina M Carroll, et al.
Contemporary Clinical Trials|November 17, 2011
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials NetworkAimee N C Campbell, Edward V Nunes, Gloria M Miele, et al.
Addiction (Abingdon, England)|July 26, 2011
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trialsDennis M Donovan, George E Bigelow, Gregory S Brigham, et al.
AIDS and Behavior|December 8, 2009
Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western KenyaRebecca K Papas, John E Sidle, Steve Martino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2003
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytesAjay Madan, Richard A Graham, Kathleen M Carroll, et al.
Cancer Research|March 26, 2009
Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cellsSudhir S Rao, Jennifer O'Neil, Cole D Liberator, et al.
Scientific Reports|June 4, 2021
Insulin micro-secretion in Type 1 diabetes and related microRNA profilesAndrzej S Januszewski, Yoon Hi Cho, Mugdha V Joglekar, et al.
Pageof 145